Ni Li, Ni Li, Yan Li, Xiaowan Han, Jing Zhang, Jiangxue Han, . . . Shuyi Si. (2022). LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing. Frontiers Media S.A..
Chicago Style (17th ed.) CitationNi Li, et al. LXR Agonist Inhibits Inflammation Through Regulating MyD88 MRNA Alternative Splicing. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationNi Li, et al. LXR Agonist Inhibits Inflammation Through Regulating MyD88 MRNA Alternative Splicing. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.